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This study tested the hypothesis that an 8-week exercise intervention supported by mobile
health (mHealth) technology would improve metabolic syndrome (MetS) risk factors and
heart rate variability (HRV) in a population with MetS risk factors. Participants (n=12; three
male; aged 56.9±7.0 years) reported to the laboratory for assessment of MetS risk factors
and fitness (VO2max) at baseline (V 0) and after 8-weeks (V 2) of intervention. Participants
received an individualized exercise prescription and a mHealth technology kit for remote
monitoring of blood pressure (BP), blood glucose, physical activity, and body weight via
smartphone. Participants underwent 24-h ambulatory monitoring of R–R intervals follow-
ing V 0 and V 2. Low and high frequency powers of HRV were assessed from the recording
and the ratio of low-to-high frequency powers and low and high frequency powers in normal-
ized units were calculated. One-way repeated measures analysis of variance showed that
waist circumference (V 0: 113.1±11.0 cm, V 2: 108.1±14.7 cm; p=0.004) and diastolic BP
(V 0: 81±6 mmHg, V 2: 76±11 mmHg; p= 0.04) were reduced and VO2max increased (V 0:
31.3 ml/kg/min, V 2: 34.8 ml/kg/min; p=0.02) with no changes in other MetS risk factors.
Low and high frequency powers in normalized units were reduced (V 0: 75.5±12.0, V 2:
72.0± 12.1; p=0.03) and increased (V 0: 24.5±12.0, V 2: 28.0±12.1; p=0.03), respec-
tively, with no other changes in HRV. Over the intervention period, changes in systolic BP
were correlated negatively with the changes in R–R interval (r =−0.600; p=0.04) and
positively with the changes in heart rate (r =0.611; p=0.03), with no other associations
between MetS risk factors and HRV parameters. Thus, this 8-week mHealth supported
exercise intervention improved MetS risk factors and HRV parameters, but only changes
in systolic BP were associated with improved autonomic function.
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INTRODUCTION
Cardiovascular diseases are the leading cause of death world-wide
accounting for 48% of mortality from non-communicable dis-
eases (1). Type 2 diabetes mellitus is an independent risk factor
for cardiovascular diseases and cardiovascular complications are
common in this patient population. Metabolic syndrome (MetS) is
a clustering of risk factors including abdominal obesity, hyperten-
sion, dysglycemia, and dyslipidemia, which doubles the 5-year risk
of developing cardiovascular diseases and increases the life-time
risk of developing type 2 diabetes mellitus fivefold (2). Lifestyle
interventions are currently recommended as first-line therapy for
MetS (2, 3).
Heart rate variability (HRV) is a simple, non-invasive mea-
sure that can be used to quantify autonomic nervous system
modulation (4). Diminished HRV predicts all cause and car-
diovascular mortality (5–8) and impaired autonomic function
may be especially dangerous for those with an already increased
risk of developing cardiovascular disease. Patients with type 2
diabetes mellitus with low HRV have double the risk of mor-
tality compared to those with normal HRV (5). Recent reviews
have suggested that autonomic dysfunction may be involved
in the development of MetS and further dysfunction may be
associated with progression along the continuum of cardio-
vascular disease (9, 10). Cross-sectional analyses have shown
that 24 h HRV is reduced in MetS populations (11, 12), which
may further increase cardiovascular risk. There is evidence that
lifestyle changes may have positive autonomic effects (13, 14)
but, it is unknown whether changes in MetS risk factors with
lifestyle modifications are associated with concomitant changes
in HRV.
We recently completed a pilot study examining the effects of
a prescriptive exercise intervention supported by mobile health
(mHealth) technology to improve MetS risk factors and clinical
markers of cardiovascular disease (15, 16). This paper reports on a
subset of participants with sufficient data for assessment of HRV in
a population presenting with MetS risk factors. Thus, the purpose
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was to test the hypothesis that an 8-week lifestyle intervention
supported by mHealth technology would improve HRV and that
changes in MetS risk factors would be related to changes in HRV
parameters.
MATERIALS AND METHODS
Twenty-five participants volunteered and provided informed con-
sent to participate in this study. Participants were included if they
had at least two MetS risk factors according to ATPIII guidelines:
waist circumference ≥88 cm (women) or 102 cm (men); resting
systolic blood pressure (SBP)≥135 mmHg and/or diastolic blood
pressure (DBP)≥85 mmHg; fasting plasma glucose≥6.1 mmol/L;
triglycerides ≥1.7 mmol/L; and high density lipoprotein cho-
lesterol (HDL) ≤1.03 mmol/L (men) or 1.29 mmol/L (women)
[National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, and Treatment of High Blood Cho-
lesterol in Adults (Adult Treatment Panel III) (17)]. Exclusion
criteria were SBP> 180 mmHg and/or DBP> 110 mmHg; type
1 diabetes; history of myocardial infarction, angioplasty, coronary
artery bypass, or cerebrovascular ischemia/stroke; symptomatic
congestive heart failure; atrial flutter; unstable angina; unstable
pulmonary disease; use of medications known to affect heart
rate (HR) (such as beta blockers); second or third degree heart
block; history of alcoholism, drug abuse, or other emotional cog-
nitive or psychiatric problems; pacemaker; unstable metabolic
disease; and orthopedic or rheumatologic problems that could
impair the ability to exercise. One participant withdrew from
the study shortly following baseline testing due to hospitaliza-
tion for a respiratory illness unrelated to the study. Twenty-four
participants (aged 56.6± 9.0 year; six male) reported to Gateway
Rural Health Research Centre at baseline (V 0) and after four (V 1)
and eight (V 2) weeks of intervention. This study was approved
by Institutional Review Board Services (Aurora, ON, Canada;
#RP-2008).
At each visit, blood pressure (BP) was measured following a
5-min rest in the seated position with an automated BP cuff
(BPTru™ VSM MedTech Ltd., Coquitlam, BC, Canada). Clinic
BP was calculated as the average of the last two of three mea-
sures taken at 2-min intervals. Waist circumference was mea-
sured as the midpoint between the lower rib and iliac crest (cm)
(18). Blood was drawn from the antecubital vein and samples
were sent to a central processing lab (Gamma Dynacare, London,
ON, Canada) for analysis of fasting plasma glucose, triglycerides,
and HDL.
The Step Test Exercise Prescription (STEP™) was administered
to estimate fitness (VO2max; ml/kg/min) and counsel participants
regarding physical activity. The full protocol is reported elsewhere
(19). Briefly, participants were instructed to step up and down a set
of 2 steps 20 times at a comfortable pace. HR was measured imme-
diately following the test by palpation of the radial artery and input
into the equation for calculation of predicted VO2max. Exercise
prescription followed American College of Sports Medicine guide-
lines (20), with a target exercise HR of 70–85% of age predicted
maximum HR, depending on VO2max. Goals included increas-
ing pedometer-monitored steps per day with the overall goal of
achieving 10,000 steps per day (21). The exercise prescription and
goals were updated at V 1.
MOBILE HEALTH PROTOCOL
Details of mHealth biometric and activity monitoring and data-
base security are reported elsewhere (15). Briefly, participants
received a smartphone (Blackberry® Curve 8300, Research in
Motion, Waterloo, ON, Canada) equipped with health monitor-
ing software (Healthanywhere™, IgeaCare Inc., Markham, ON,
Canada), a Bluetooth™ enabled BP monitor (A&D Medical,
UA-767PBT, San Jose, CA, USA), a glucometer (LifeScan One-
Touch Ultra2™, Milpitas, CA, USA, with wireless Bluetooth™
adapter Polymap,PWR-08-03,Tucson,AZ,USA),and a pedometer
(Omron,HJ-150,Kyoto, Japan). Blood glucose measures were to be
submitted twice daily (fasted upon waking and non-fasted before
bed), BP measures were to be submitted three times per week upon
waking, pedometer steps were to be input nightly, and body weight
input weekly. Real-time measurements were sent to a secure cen-
tral database that was monitored regularly by researchers. Readings
that were outside of pre-set limits triggered alarms that automati-
cally sent a message to the study physician’s smartphone to follow
up with the participant.
The participants underwent ambulatory 24-h recording of R–
R intervals on their least active day during the week immediately
followingV 0 andV 2 visits. R–R interval recording was conducted
using a HR monitor with sampling accuracy of 1 ms (Suunto
Memory Belt, Vantaa, Finland). Data were downloaded from the
monitor to a personal computer for subsequent analysis (Heart
Signal Co, Oulu, Finland). Frequency domain analysis for 24-h
HRV was calculated as the average of 1 h epochs. An autoregressive
model (order 20) was used to estimate power spectrum density for
low (0.04–0.15 Hz) and high frequency powers (0.15–0.4 Hz) (4).
Low and high frequency powers were also expressed in normalized
units by dividing the low and high frequency power, respectively,
by the sum of the low and high frequency power and multiply-
ing by 100. Recordings with <80% qualifying beats were excluded
from analysis.
STATISTICAL ANALYSIS
SigmaPlot (Version 11.0, Systat Software, San Jose, CA, USA) was
used for analysis. One-way repeated measures analysis of vari-
ance was used to examine changes in MetS risk factors and HRV
parameters fromV 0 toV 2. Normality was tested with the Shapiro–
Wilks test. Low and high frequency powers of HRV were logarith-
mically transformed to achieve normal distribution. Spearman
rank order correlation was used to examine correlation between
change in MetS risk factors and change in HRV over the course of
the intervention. Spearman rank order correlation was used since
mean change was not normally distributed and since the sample
size was small. Data are shown as mean± SD and significance was
set at p< 0.05.
RESULTS
Participant characteristics, clinic, and home-monitoring results
for the full population have been reported elsewhere (15, 16).
Twelve participants (aged 44–69 year) had acceptable 24 h HRV
recordings at both V 0 and V 2. Baseline characteristics for this
subgroup and changes in MetS risk factors are reported in
Table 1. Similar to the full population, this subgroup showed
reductions in waist circumference (V 0: 113.1± 11.0 cm, V 2:
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Table 1 | Participant characteristics and changes in metabolic
syndrome risk factors fromV 0 toV 2.
V 0 V 2 p-Value
N 12 (3 Male; 25%)
Age (year) 56.9±7.0
WC (cm) 113.1±11.0 108.1±14.7 0.002*
SBP (mmHg) 139±7 134±12 0.15
DBP (mmHg) 81±6 76±11 0.04*
FPG (mmol/L) 5.5±0.9 5.4±1.0 0.59
TG (mmol/L) 1.85±1.64 1.42±0.78 0.22
HDL (mmol/L) 1.35±0.35 1.41±0.46 0.19
VO2max (ml/kg/min) 31.3±6.7 34.8±8.7 0.02*
DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL, high density
lipoprotein cholesterol; SBP, systolic blood pressure; TG, triglycerides; VO2max,
predicted maximal oxygen capacity; WC, waist circumference, *p< 0.05.
108.1± 14.7 cm; p= 0.004) and DBP (V 0: 81± 6 mmHg, V 2:
76± 11 mmHg; p= 0.04) with no changes in SBP, fasting plasma
glucose, triglycerides, or HDL. Additionally, VO2max increased
from 31.3 ml/kg/min at V 0 to 34.8 ml/kg/min at V 2 (p= 0.02).
The average of pedometer steps per day entered during week 1
and 8 were calculated to determine physical activity at V 0 and V 2,
respectively. Over the intervention period, daily steps increased
from 6472± 1997 steps per day atV 0 to 8376± 2285 steps per day
at V 2.
High frequency power in normalized units increased from
24.5± 12.0 at V 0 to 28.0± 12.1 at V 2 (p= 0.03) and low fre-
quency power in normalized units decreased from 75.5± 12.0 at
V 0 to 72.0± 12.1 atV 2 (p= 0.03). There were no changes in other
24 h HRV variables (Table 2).
Correlation analysis showed that the change in SBP was
inversely associated with the change in R–R interval (−0.600,
p= 0.04) and positively associated with the change in HR (0.611,
p= 0.03). There were no other relationships between changes in
MetS risk factors and changes in HRV parameters (Table 3).
DISCUSSION
The main finding of this study was that a prescriptive exercise
intervention supported by mHealth technology improved HRV
by increasing and decreasing high and low frequency powers in
normalized units, respectively. Additionally, the change in SBP
was correlated with the change in R–R interval and HR.
Frequency domain analysis of HRV is commonly used since
the different frequency bands are believed to reflect physiolog-
ical processes (4). Specifically, it is generally accepted that the
high frequency band reflects parasympathetic modulation, though
there is some debate over the physiological significance of the low
frequency band (4). The low frequency band may represent a com-
bination of sympathetic and parasympathetic activity (4) or may
be reflective of baroreflex activity (22, 23). There is evidence to
suggest that when low frequency power is expressed in normalized
units, it is reflective of sympathetic activity (24). Thus, the increase
in high frequency power and decrease in low frequency power
expressed in normalized units may indicate positive modifications
Table 2 |Twenty-hour heart rate variability before and after the 8-week
intervention.
V 0 V 2 p-Value
RRI (ms) 822±127 849±131 0.29
HR (bpm) 75±11 72±11 0.08
lnLF (ms2) 6.39±0.78 6.41±0.85 0.73
lnHF (ms2) 5.18±1.00 5.39±1.09 0.11
LFnu 75.5±12.0 72.0±12.1 0.03*
HFnu 24.5±12.0 28.0±12.1 0.03*
LF/HF 3.9±2.0 3.4±2.6 0.22
bpm, Beats per minute; HF, high frequency power; HFnu, high frequency power
in normalized units; HR, heart rate; LF, low frequency power; LFnu, low frequency
power in normalized units; RRI, R–R interval, *significant with p<0.05.
in autonomic activity with an increase in parasympathetic and
decrease in sympathetic activity following the intervention.
EXERCISE AND HRV
Exercise training is recommended as first-line treatment for MetS
(2, 3) and has proved to effectively improve waist circumference,
BP,and HDL in MetS populations (25). Additionally, lifestyle inter-
ventions combining diet and exercise reduced incident type 2 dia-
betes mellitus in a population of adults with MetS risk factors (26,
27). In the DaTA pilot study, the 8-week mHealth supported exer-
cise intervention reduced DBP and total cholesterol and increased
predicted VO2max (16). There is some evidence to suggest that
exercise may also have positive effects on HRV, but results are
mixed. In an early study, young adults with mild hypertension
completed 22 min of calisthenics followed by 20 min of jogging
a minimum of five times per week (28). Upon completion of the
intervention, resting R–R interval was increased and, similar to the
present study,high and low frequency powers expressed in normal-
ized units were increased and reduced, respectively, demonstrating
improved autonomic balance (28). Exercise training interventions,
of moderate-to-vigorous intensity in middle-aged to older men
(13, 29, 30) and a lower intensity exercise intervention at 50% of
VO2max in post-menopausal women also showed improvements
in HRV (31). One study in patients with type 2 diabetes mel-
litus with and without cardiac autonomic neuropathy showed
improvement in HRV parameters following 6 months of aero-
bic exercise three times per week at 70–85% of HR reserve (32).
Conversely, one study showed no change in HRV parameters at
rest or during exercise in older men and women after 8 weeks
of aerobic exercise training three times per week for 60 min each
session (33).
Other studies found that while resting HRV was not altered
with endurance training, HRV was altered during or after expo-
sure to stressors (34, 35). In obese women with and without type 2
diabetes mellitus, 16 weeks of moderate intensity endurance train-
ing (65% VO2max) 4 days per week increased post-exercise HR
recovery and post-exercise high and low frequency powers with
no changes in resting HRV (34). Six months of exercise training
2 days per week for 70 min at moderate intensity did not affect
resting HRV in patients with type 2 diabetes mellitus, but high fre-
quency power in normalized units was increased and the ratio of
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Table 3 | Correlation coefficients for changes in heart rate variability parameters and metabolic syndrome risk factors over the intervention
period.
∆RRI ∆HR ∆lnLF ∆lnHF ∆LFnu ∆HFnu ∆LF/HF
Age 0.242 −0.246 −0.112 −0.203 0.263 −0.263 0.305
0.43 0.43 0.71 0.51 0.39 0.39 0.32
∆WC −0.152 0.196 0.349 0.543 −0.536 0.536 −0.455
0.62 0.53 0.25 0.06 0.07 0.07 0.13
∆SBP −0.600 0.611 −0.294 −0.046 −0.221 0.221 −0.329
0.04* 0.03* 0.34 0.87 0.47 0.47 0.28
∆DBP −0.305 0.378 −0.273 −0.119 −0.070 0.070 −0.105
0.32 0.21 0.38 0.70 0.82 0.82 0.73
∆FPG −0.061 0.066 −0.424 0.084 −0.529 0.529 −0.518
0.83 0.83 0.16 0.78 0.07 0.07 0.08
∆TG −0.326 0.372 −0.462 −0.329 −0.151 0.151 −0.214
0.28 0.22 0.12 0.28 0.62 0.62 0.48
∆HDL −0.063 −0.050 −0.102 −0.287 0.182 −0.182 0.147
0.83 0.87 0.73 0.35 0.56 0.56 0.64
∆VO2max 0.123 −0.191 0.203 0.168 0.007 −0.007 −0.007
0.68 0.54 0.51 0.59 0.97 0.97 0.97
∆Steps 0.476 −0.438 0.035 0.406 −0.336 0.336 −0.280
0.11 0.14 0.90 0.18 0.27 0.27 0.36
DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL, high density lipoprotein cholesterol; HF, high frequency power; HFnu, high frequency power in
normalized units; HR, heart rate; LF, low frequency power; LFnu, low frequency power in normalized units; RRI, R–R interval; SBP, systolic blood pressure; TG,
triglycerides; VO2max, predicted maximal oxygen capacity; WC, waist circumference, *significant with p<0.05.
Data presented as Spearman rank order correlation coefficient and p-value.
low-to-high frequency powers was reduced during an orthostatic
challenge (35). Thus, inclusion of an acute stressor to the study
protocol may have revealed additional alterations in autonomic
activity following the intervention.
Frequency of exercise training may be an important factor, as
those with sessions five to six times per week (13, 28, 30) showed
improved HRV, while in those with training sessions four times
per week or less, results were mixed. In four studies that did not
show changes in resting autonomic function, exercise training fre-
quency was only two or three times per week or only one session
per week was supervised and the remaining were completed at
home, so compliance to the exercise protocol may not be as high
as reported. Since the exercise prescription in the present study
included attainment of 10,000 steps daily along with other more
specific aerobic exercises at moderate-to-vigorous intensity, the
frequent exercise bouts may have been responsible for the improve-
ments in high and low frequency powers in normalized units.
Unfortunately, only pedometer steps were recorded and other
activities were not logged, so frequency and intensity of exercise
completed throughout the intervention cannot be quantified.
Age may play an important role in the response of HRV to
exercise. Lee and colleagues (36) used low dose atropine (which
augments parasympathetic activity, as opposed to higher doses,
which are inhibitory) to provoke autonomic changes in younger
and older fit and unfit individuals. Resting R–R interval was
increased more in fit compared to unfit individuals in the younger
age group. However, the responses to atropine in the older age
group were not affected by fitness status (36). Thus the lack of
change in HRV in response to exercise training in older adults
may be due to reduced function or sensitivity of the sinus node
with age, which may not be modified with intervention. One study
in older women showed that exercise improved HRV when 50, 100,
or 150% of national exercise guidelines was completed. However,
in women aged >60 year, there were no improvements at lower
exercise doses, suggesting that a higher dose of exercise may be nec-
essary to evoke autonomic changes in older adults (37). Though
our sample was on average older, it included a range of ages. Inter-
estingly, age was not correlated with change in any HRV parameter
in this study.
In the Diabetes Prevention Program, an intensive lifestyle inter-
vention including physical activity and a low fat diet reduced HR
and increased HRV parameters indicative of overall or beat-by-
beat variability (reflecting parasympathetic activity) compared to
metformin or placebo (38). Importantly, reductions in HR and
increases in HRV over time were associated with lower risk of
incident diabetes, independent of weight loss, and physical activ-
ity in the lifestyle modification group, supporting the use of HRV
or perhaps the change in HRV in response to an intervention,
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as a risk indicator (38). HRV was measured from 10 s ECG seg-
ments, so frequency domain parameters could not be examined,
which also have important prognostic power. Nevertheless, these
results are promising and suggest that lifestyle modifications are
important for risk reduction in a diabetes prevention strategy.
Improvements in autonomic function may have positive effects in
the long-term. Longitudinal follow-up studies are warranted to
examine the effects of improved HRV on prognosis.
HRV AND MetS
To our knowledge, this study was the first to examine correla-
tion between the change in HRV parameters and the change in
MetS risk factors over an intervention period. The change in SBP
was strongly and inversely associated with changes in R–R interval
and positively associated with changes in HR. These findings are
in accordance with previous studies that have shown reduced BP
and HR with endurance exercise training (39). The correlations
between changes MetS risk factors and changes in HRV parame-
ters over an intervention period are not the same as cross-sectional
associations between 24 h HRV and MetS risk factors. Assoumou
et al. (11) showed associations between hypertension and total
power, but did not examine relationships with SBP and DBP
individually. Their study showed a negative association between
fasting plasma glucose and high frequency power of HRV (11),
while the present study showed no associations between fasting
plasma glucose and HRV parameters. When sex differences were
examined triglycerides were only associated with HRV in men,
but not women and fasting plasma glucose was negatively asso-
ciated with high frequency power and positively associated with
ratio of low-to-high frequency powers in women with no associ-
ations in men (11). In a cohort of men with MetS, all MetS risk
factors except HDL were associated with HRV parameters (12).
Notably, these authors showed that each one unit increment in
the number of MetS components reduced low frequency power
of HRV by 15% (12), highlighting the importance of treating and
controlling all MetS components. Liao and colleagues (40) exam-
ined 2-min HRV in people with what they termed multiple MetS,
which could be any combination of hypertension, type 2 dia-
betes mellitus, and dyslipidemia. Interestingly, they showed that
the combination of risk factors presenting together determined
the HRV outcome. When hypertension was present in combi-
nation with either type 2 diabetes mellitus or dyslipidemia, the
reductions in HRV were additive, but when type 2 diabetes melli-
tus and dyslipidemia presented together, reductions in HRV were
multiplicative (40). These findings may account for differences
between the present study and others, as specific combinations
of risk factors may be more important contributors to HRV than
individual MetS components. The sample size for this pilot project
was too small to include an analysis based on the change in MetS
risk factors, but such analyses are important for future studies.
Additionally, the present study was the first to examine associa-
tions between longitudinal changes in HRV and changes in MetS,
which may be different than cross-sectional associations.
In this study, changes in waist circumference were not signifi-
cantly correlated with changes in HRV. There was however,a strong
trend (p= 0.06) for a negative association between the change in
waist circumference and the change in high frequency power of
HRV, suggesting that reductions in waist circumference may not
be associated with improvements in HRV, but rather with declines
in HRV. On the contrary, Hautala and colleagues (13) showed
that an 8-week intervention with supervised exercise training ses-
sions six times per week at 70–80% of maximum HR improved
HRV. The change in body mass index was moderately correlated
with the change in high frequency power following the subse-
quent 10-week home-based maintenance program, despite the fact
that overall improvements in HRV were not maintained during
this period (13). Furthermore, in a small sample of abdominally
obese men and women, weight loss with a very low calorie diet
increased total and low frequency power of HRV (41). However,
despite weight maintenance over a 1-year period, improvements in
HRV were not sustained (41). These studies suggest that improve-
ments in HRV with lifestyle interventions may be transient. Long-
term studies to determine effective strategies for maintenance of
HRV improvements with exercise or weight loss interventions are
needed.
LIMITATIONS
This pilot study was conducted in a sample of highly motivated
volunteers and may therefore lack external validation. Despite the
fact that only 12 participants had acceptable HR data for 24 h HRV
analysis, modifications were seen in high and low frequency pow-
ers of HRV when expressed in normalized units. However, this
analysis was underpowered and a larger sample size would have
been ideal and may have shown greater change. Although Suunto
activity monitor has been validated, our participants had diffi-
culties putting the monitor on properly to collect heart period.
Additionally, some participants reported discomfort and removed
the monitor during the nighttime period due to disturbed sleep.
Traditional Holter monitors may be preferable to improve data
quality and participant comfort. This exploratory pilot study used
correlation analysis to examine relationships between MetS risk
factors and HRV parameters. Unfortunately, correlation cannot
show direction of association. Additionally, previous studies have
shown sex differences in associations between MetS risk factors
and HRV (11), but the sample for this pilot study was not suffi-
ciently powered to examine sex differences. Nevertheless, poten-
tially important relationships were identified in this sample. Future
studies examining relationships and sex differences in a larger
population are warranted.
In conclusion, an 8-week exercise prescription supported by
mHealth technologies for biometric and activity monitoring
improved 24 h HRV profile with increased high frequency power
of HRV in normalized units and reduced low frequency power of
HRV in normalized units, suggesting improved autonomic bal-
ance. Additionally, changes in SBP were associated with changes
in R–R interval and HR.
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